{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:02:58Z","timestamp":1790089378725,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"DOI":"10.1186\/s12868-026-01007-4","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:15:14Z","timestamp":1779768914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective effects of sulfasalazine in experimental model of seizures and epilepsy"],"prefix":"10.1186","volume":"27","author":[{"given":"Sree Lalitha","family":"Bojja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangadhar","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilora","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran Kumar","family":"Kolathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-8135","authenticated-orcid":false,"given":"Mallikarjuna Rao","family":"Chamallamudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"1","key":"1007_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/J.1476-5381.2011.01480.X","volume":"165","author":"RJ Bridges","year":"2012","unstructured":"Bridges RJ, Natale NR, Patel SA. System xc- cystine\/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol. 2012;165(1):20. https:\/\/doi.org\/10.1111\/J.1476-5381.2011.01480.X.","journal-title":"Br J Pharmacol"},{"key":"1007_CR2","doi-asserted-by":"publisher","unstructured":"Satarker S, Bojja SL, Gurram PC, Mudgal J, Arora D, Nampoothiri M. Astrocytic Glutamatergic transmission and its implications in neurodegenerative disorders. Cells. 2022;11(7). https:\/\/doi.org\/10.3390\/CELLS11071139.","DOI":"10.3390\/CELLS11071139"},{"issue":"18","key":"1007_CR3","doi-asserted-by":"publisher","first-page":"9718","DOI":"10.3390\/IJMS22189718","volume":"22","author":"CC Hung","year":"2021","unstructured":"Hung CC, Lin CH, Lane HY. Cystine\/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment. Int J Mol Sci 2021. 2021;22(18):9718. https:\/\/doi.org\/10.3390\/IJMS22189718. 22.","journal-title":"Int J Mol Sci 2021"},{"issue":"1","key":"1007_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1535759719891983","volume":"20","author":"M Gallagher","year":"2020","unstructured":"Gallagher M. The System xc- Cystine\/Glutamate Antiporter: An Exciting Target for Antiepileptogenic Therapy? Epilepsy Currents. 2020;20(1):39. https:\/\/doi.org\/10.1177\/1535759719891983.","journal-title":"Epilepsy Currents"},{"key":"1007_CR5","doi-asserted-by":"publisher","first-page":"821036","DOI":"10.3389\/FNCEL.2022.821036\/FULL","volume":"16","author":"Y He","year":"2022","unstructured":"He Y. The Cystine\/Glutamate Antiporter, System xc\u2013, Contributes to Cortical Infarction After Moderate but Not Severe Focal Cerebral Ischemia in Mice. Front Cell Neurosci. 2022;16:821036. https:\/\/doi.org\/10.3389\/FNCEL.2022.821036\/FULL.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1007_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-016-0787-0\/FIGURES\/6","volume":"14","author":"E Merckx","year":"2017","unstructured":"Merckx E, Albertini G, Paterka M, Jensen C, Albrecht P, Dietrich M, Van Liefferinge J, Bentea E, Verbruggen L, Demuyser T, Deneyer L, Lewerenz J, van Loo G, De Keyser J, Sato H, Maher P, Methner A, Massie A. Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis. J Neuroinflamm. 2017;14(1):1\u201316. https:\/\/doi.org\/10.1186\/S12974-016-0787-0\/FIGURES\/6.","journal-title":"J Neuroinflamm"},{"key":"1007_CR7","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/J.REDOX.2020.101494","volume":"32","author":"A Ashraf","year":"2020","unstructured":"Ashraf A, Jeandriens J, Parkes HG, So PW. Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in Alzheimer\u2019s disease: Evidence of ferroptosis. Redox Biol. 2020;32:101494. https:\/\/doi.org\/10.1016\/J.REDOX.2020.101494.","journal-title":"Redox Biol"},{"issue":"6","key":"1007_CR8","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/JNC.13348","volume":"135","author":"A Massie","year":"2015","unstructured":"Massie A, Boill\u00e9e S, Hewett S, Knackstedt L, Lewerenz J. Main path and byways: Non-vesicular glutamate release by system xc- as an important modifier of glutamatergic neurotransmission. J Neurochem. 2015;135(6):1062\u201379. https:\/\/doi.org\/10.1111\/JNC.13348.","journal-title":"J Neurochem"},{"issue":"7","key":"1007_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/EPI.16073","volume":"60","author":"O Alcoreza","year":"2019","unstructured":"Alcoreza O, Tewari BP, Bouslog A, Savoia A, Sontheimer H, Campbell SL. Sulfasalazine decreases mouse cortical hyperexcitability. Epilepsia. 2019;60(7):1365\u201377. https:\/\/doi.org\/10.1111\/EPI.16073.","journal-title":"Epilepsia"},{"issue":"7","key":"1007_CR10","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/EPI.16055","volume":"60","author":"K Leclercq","year":"2019","unstructured":"Leclercq K, Liefferinge J, Van, Albertini G, Neveux M, Dardenne S, Mairet-Coello G, Vandenplas C, Deprez T, Chong SA, Foerch P, Bentea E, Sato H, Maher P, Massie A, Smolders I, Kaminski RM. Anticonvulsant and antiepileptogenic effects of system xc\u2013 inactivation in chronic epilepsy models. Epilepsia. 2019;60(7):1412\u201323. https:\/\/doi.org\/10.1111\/EPI.16055.","journal-title":"Epilepsia"},{"issue":"1","key":"1007_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/epi4.12307","volume":"4","author":"SMS Sears","year":"2019","unstructured":"Sears SMS, Hewett JA, Hewett SJ. Decreased epileptogenesis in mice lacking the System xc - transporter occurs in association with a reduction in AMPA receptor subunit GluA1. Epilepsia open. 2019;4(1):133\u201343. https:\/\/doi.org\/10.1002\/epi4.12307.","journal-title":"Epilepsia open"},{"issue":"5","key":"1007_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1172\/JCI992","volume":"101","author":"C Wahl","year":"1998","unstructured":"Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998;101(5):1163. https:\/\/doi.org\/10.1172\/JCI992.","journal-title":"J Clin Invest"},{"issue":"5","key":"1007_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1517\/13543784.2012.670634","volume":"21","author":"H Sontheimer","year":"2012","unstructured":"Sontheimer H, Bridges RJ. Sulfasalazine for brain cancer fits. Expert Opin Investig Drugs. 2012;21(5):575\u20138. https:\/\/doi.org\/10.1517\/13543784.2012.670634.","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"1007_CR14","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/S11064-019-02901-6\/FIGURES\/2","volume":"45","author":"M Nehser","year":"2020","unstructured":"Nehser M, Dark J, Schweitzer D, Campbell M, Zwicker J, Hitt DM, Little H, Diaz-Correa A, Holley DC, Patel SA, Thompson CM, Bridges RJ. System X c\u2013 Antiporter Inhibitors: Azo-Linked Amino-Naphthyl-Sulfonate Analogues of Sulfasalazine. Neurochem Res. 2020;45(6):1375\u201386. https:\/\/doi.org\/10.1007\/S11064-019-02901-6\/FIGURES\/2.","journal-title":"Neurochem Res"},{"issue":"10","key":"1007_CR15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/NM.2453","volume":"17","author":"SC Buckingham","year":"2011","unstructured":"Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H. Glutamate release by primary brain tumors induces epileptic activity. Nat Med. 2011;17(10):1269\u201374. https:\/\/doi.org\/10.1038\/NM.2453.","journal-title":"Nat Med"},{"key":"1007_CR16","doi-asserted-by":"publisher","first-page":"107750","DOI":"10.1016\/J.NEUROPHARM.2019.107750","volume":"167","author":"M Barker-Haliski","year":"2019","unstructured":"Barker-Haliski M, Steve White H. Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening. Neuropharmacology. 2019;167:107750. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2019.107750.","journal-title":"Neuropharmacology"},{"issue":"6","key":"1007_CR17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/J.BBADIS.2019.01.026","volume":"1865","author":"P Ambrogini","year":"2019","unstructured":"Ambrogini P, Torquato P, Bartolini D, Albertini MC, Lattanzi D, Di Palma M, Marinelli R, Betti M, Minelli A, Cuppini R, Galli F. Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E. Biochim et Biophys acta Mol basis disease. 2019;1865(6):1098\u2013112. https:\/\/doi.org\/10.1016\/J.BBADIS.2019.01.026.","journal-title":"Biochim et Biophys acta Mol basis disease"},{"key":"1007_CR18","doi-asserted-by":"publisher","unstructured":"Meenu M, Reeta KH, Dinda AK, Kottarath SK, Gupta YK. Evaluation of sodium valproate loaded nanoparticles in acute and chronic pentylenetetrazole induced seizure models. Epilepsy Res. 2019;158. https:\/\/doi.org\/10.1016\/J.EPLEPSYRES.2019.106219.","DOI":"10.1016\/J.EPLEPSYRES.2019.106219"},{"key":"1007_CR19","doi-asserted-by":"publisher","unstructured":"Suarez-Almazor ME, Belseck E, Shea B, Tugwell P, Wells GA. Sulfasalazine for treating rheumatoid arthritis. Cochrane Database Syst Rev. 1998;2. https:\/\/doi.org\/10.1002\/14651858.CD000958.","DOI":"10.1002\/14651858.CD000958"},{"issue":"15","key":"1007_CR20","doi-asserted-by":"publisher","first-page":"12405","DOI":"10.3390\/IJMS241512405\/S1","volume":"24","author":"VA Aleshin","year":"2023","unstructured":"Aleshin VA, Graf AV, Artiukhov AV, Ksenofontov AL, Zavileyskiy LG, Maslova MV, Bunik VI. Pentylenetetrazole-Induced Seizures Are Increased after Kindling, Exhibiting Vitamin-Responsive Correlations to the Post-Seizures Behavior, Amino Acids Metabolism and Key Metabolic Regulators in the Rat Brain. Int J Mol Sci. 2023;24(15):12405. https:\/\/doi.org\/10.3390\/IJMS241512405\/S1.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1007_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/J.YEBEH.2013.06.007","volume":"29","author":"A Kumar","year":"2013","unstructured":"Kumar A, Lalitha S, Mishra J. Possible nitric oxide mechanism in the protective effect of hesperidin against pentylenetetrazole (PTZ)-induced kindling and associated cognitive dysfunction in mice. Epilepsy Behav. 2013;29(1):103\u201311. https:\/\/doi.org\/10.1016\/J.YEBEH.2013.06.007.","journal-title":"Epilepsy Behav"},{"key":"1007_CR22","doi-asserted-by":"publisher","first-page":"149138","DOI":"10.1016\/J.BRAINRES.2024.149138","volume":"1844","author":"SL Bojja","year":"2024","unstructured":"Bojja SL, Anand S, Minz RW, Medhi B. Metformin alleviates reactive gliosis and neurodegeneration, improving cognitive deficit in a rat model of temporal lobe epilepsy. Brain Res. 2024;1844:149138. https:\/\/doi.org\/10.1016\/J.BRAINRES.2024.149138.","journal-title":"Brain Res"},{"issue":"1","key":"1007_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/S10787-020-00782-8\/FIGURES\/9","volume":"29","author":"SL Bojja","year":"2021","unstructured":"Bojja SL, Medhi B, Anand S, Bhatia A, Joshi R, Minz RW. Metformin ameliorates the status epilepticus- induced hippocampal pathology through possible mTOR modulation. Inflammopharmacology. 2021;29(1):137\u201351. https:\/\/doi.org\/10.1007\/S10787-020-00782-8\/FIGURES\/9.","journal-title":"Inflammopharmacology"},{"key":"1007_CR24","doi-asserted-by":"crossref","unstructured":"Hang TD, Hung HM, Beckers P, Desmet N, Lamrani M, Massie A, Hermans E, Vanommeslaeghe K. Structural investigation of human cystine\/glutamate antiporter system xc\u2013 (Sxc\u2013) using homology modeling and molecular dynamics. Front Mol Biosci. 2022;9:1064199. https:\/\/doi.org\/10.3389\/FMOLB.2022.1064199\/BIBTEX.","DOI":"10.3389\/fmolb.2022.1064199"},{"issue":"2","key":"1007_CR25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1039\/D3NR04733D","volume":"16","author":"J Lim","year":"2024","unstructured":"Lim J, Lee J, Boo Y, Kim WJ. A polymeric iron oxide nanocomplex loaded with sulfasalazine: an approach for inducing ferritinophagy-assisted ferroptosis for anti-cancer therapy. Nanoscale. 2024;16(2):742\u201351. https:\/\/doi.org\/10.1039\/D3NR04733D.","journal-title":"Nanoscale"},{"key":"1007_CR26","doi-asserted-by":"publisher","unstructured":"Sleire L, Skeie BS, Netland IA, F\u00f8rde HE, Dodoo E, Selheim F, Leiss L, Heggdal JI, Pedersen P-H, Wang J, Enger P \u00d8. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc\u2013, leading to glutathione depletion. nature.comL Sleire, BS Skeie, IA Netland, HE F\u00f8rde, E Dodoo, F Selheim, L Leiss, JI HeggdalOncogene, 2015\u2022nature.com. 2015;34:5951\u20135959. https:\/\/doi.org\/10.1038\/onc.2015.60.","DOI":"10.1038\/onc.2015.60"},{"key":"1007_CR27","doi-asserted-by":"publisher","first-page":"122411","DOI":"10.1016\/J.LFS.2023.122411","volume":"339","author":"T Takatani-Nakase","year":"2024","unstructured":"Takatani-Nakase T, Ikushima C, Sakitani M, Nakase I. Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer. Life Sci. 2024;339:122411. https:\/\/doi.org\/10.1016\/J.LFS.2023.122411.","journal-title":"Life Sci"},{"issue":"1","key":"1007_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/S13402-019-00474-8\/FIGURES\/6","volume":"43","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Luo G, Shi X, Long Y, Shen W, Li Z, Zhang X. The Xc\u2013 inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism. Cell Oncol. 2020;43(1):95\u2013106. https:\/\/doi.org\/10.1007\/S13402-019-00474-8\/FIGURES\/6.","journal-title":"Cell Oncol"},{"key":"1007_CR29","doi-asserted-by":"publisher","first-page":"114559","DOI":"10.1016\/J.BBR.2023.114559","volume":"452","author":"S Wang","year":"2023","unstructured":"Wang S, Liu Y, Wu Z, Jin Y, Zhang T, Yang Z, Liu C. Inhibition of xCT by sulfasalazine alleviates the depression-like behavior of adult male mice subjected to maternal separation stress. Behav Brain Res. 2023;452:114559. https:\/\/doi.org\/10.1016\/J.BBR.2023.114559.","journal-title":"Behav Brain Res"},{"key":"1007_CR30","doi-asserted-by":"publisher","unstructured":"D\u2019ezio V, Colasanti M, Persichini T. Amyloid-25\u201335 induces neurotoxicity through the up-regulation of astrocytic system Xc? Antioxidants. 2021;10(11):1685. https:\/\/doi.org\/10.3390\/ANTIOX10111685.","DOI":"10.3390\/ANTIOX10111685"},{"issue":"1","key":"1007_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-024-03112-9\/FIGURES\/7","volume":"21","author":"P Beckers","year":"2024","unstructured":"Beckers P, Belo Do Nascimento I, Charlier M, Desmet N, Massie A, Hermans E. Implication of system xc\u2009\u2013\u2009in neuroinflammation during the onset and maintenance of neuropathic pain. J Neuroinflamm. 2024;21(1):1\u201318. https:\/\/doi.org\/10.1186\/S12974-024-03112-9\/FIGURES\/7.","journal-title":"J Neuroinflamm"},{"key":"1007_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/J.EPLEPSYRES.2016.05.016","volume":"126","author":"W L\u00f6scher","year":"2016","unstructured":"L\u00f6scher W. Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies. Epilepsy Res. 2016;126:157\u201384. https:\/\/doi.org\/10.1016\/J.EPLEPSYRES.2016.05.016.","journal-title":"Epilepsy Res"},{"issue":"1","key":"1007_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.EPLEPSYRES.2003.08.001","volume":"56","author":"ME Barton","year":"2003","unstructured":"Barton ME, Peters SC, Shannon HE. Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models. Epilepsy Res. 2003;56(1):17\u201326. https:\/\/doi.org\/10.1016\/J.EPLEPSYRES.2003.08.001.","journal-title":"Epilepsy Res"},{"issue":"2","key":"1007_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1517\/14740338.2011.529898","volume":"10","author":"V Linares","year":"2011","unstructured":"Linares V, Alonso V, Domingo JL. Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity. Exp Opin Drug Saf. 2011;10(2):253\u201363. https:\/\/doi.org\/10.1517\/14740338.2011.529898.","journal-title":"Exp Opin Drug Saf"},{"issue":"7","key":"1007_CR35","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/S11011-021-00823-3\/TABLES\/5","volume":"36","author":"T Singh","year":"2021","unstructured":"Singh T, Mishra A, Goel RK. PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability. Metab Brain Dis. 2021;36(7):1573\u201390. https:\/\/doi.org\/10.1007\/S11011-021-00823-3\/TABLES\/5.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"1007_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.NEUROPHARM.2005.07.020","volume":"50","author":"JH Noh","year":"2006","unstructured":"Noh JH, Gwag BJ, Chung JM. Underlying mechanism for NMDA receptor antagonism by the anti-inflammatory drug, sulfasalazine, in mouse cortical neurons. Neuropharmacology. 2006;50(1):1\u201315. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2005.07.020.","journal-title":"Neuropharmacology"},{"issue":"1","key":"1007_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1124\/JPET.102.042606","volume":"305","author":"BR Ryu","year":"2003","unstructured":"Ryu BR, Lee YA, Won SJ, Noh JH, Chang SY, Chung JM, Choi JS, Joo CK, Yoon SH, Gwag BJ. The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors. J Pharmacol Exp Ther. 2003;305(1):48\u201356. https:\/\/doi.org\/10.1124\/JPET.102.042606.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1007_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/JCM11010267","volume":"11","author":"A Novak","year":"2022","unstructured":"Novak A, Vizjak K, Rakusa M. Cognitive Impairment in People with Epilepsy. J Clin Med 2022. 2022;11(1):267. https:\/\/doi.org\/10.3390\/JCM11010267. 11.","journal-title":"J Clin Med 2022"},{"key":"1007_CR39","doi-asserted-by":"publisher","unstructured":"Wang L, Chen S, Liu C, Lin W, Huang H. Factors for cognitive impairment in adult epileptic patients. Brain Behav. 2020;10(1). https:\/\/doi.org\/10.1002\/BRB3.1475.","DOI":"10.1002\/BRB3.1475"},{"issue":"6","key":"1007_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/J.TIPS.2016.03.001","volume":"37","author":"A Dey","year":"2016","unstructured":"Dey A, Kang X, Qiu J, Du Y, Jiang J. Anti-inflammatory small molecules to treat seizures and epilepsy: from bench to bedside. Trends Pharmacol Sci. 2016;37(6):463. https:\/\/doi.org\/10.1016\/J.TIPS.2016.03.001.","journal-title":"Trends Pharmacol Sci"},{"key":"1007_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/J.TAAP.2017.09.014","volume":"334","author":"MH Chou","year":"2017","unstructured":"Chou MH, Wang JY, Lin CL, Chung WS. DMARD use is associated with a higher risk of dementia in patients with rheumatoid arthritis: A propensity score-matched case\u2013control study. Toxicol Appl Pharmcol. 2017;334:217\u201322. https:\/\/doi.org\/10.1016\/J.TAAP.2017.09.014.","journal-title":"Toxicol Appl Pharmcol"},{"issue":"3","key":"1007_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1515\/REVNEURO-2017-0043\/MACHINEREADABLECITATION\/RIS","volume":"29","author":"S Lalitha","year":"2018","unstructured":"Lalitha S, Minz RW, Medhi B. Understanding the controversial drug targets in epilepsy and pharmacoresistant epilepsy. Rev Neurosci. 2018;29(3):333\u201345. https:\/\/doi.org\/10.1515\/REVNEURO-2017-0043\/MACHINEREADABLECITATION\/RIS.","journal-title":"Rev Neurosci"},{"key":"1007_CR43","doi-asserted-by":"publisher","first-page":"741244","DOI":"10.3389\/FNEUR.2022.741244\/BIBTEX","volume":"13","author":"G Costagliola","year":"2022","unstructured":"Costagliola G, Depietri G, Michev A, Riva A, Foiadelli T, Savasta S, Bonuccelli A, Peroni D, Consolini R, Marseglia GL, Orsini A, Striano P. Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications. Front Neurol. 2022;13:741244. https:\/\/doi.org\/10.3389\/FNEUR.2022.741244\/BIBTEX.","journal-title":"Front Neurol"},{"issue":"1","key":"1007_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-018-1192-7","volume":"15:1","author":"A Rana","year":"2018","unstructured":"Rana A, Musto AE. The role of inflammation in the development of epilepsy. J Neuroinflammation 2018. 2018;15:1(1):1\u201312. https:\/\/doi.org\/10.1186\/S12974-018-1192-7. 15.","journal-title":"J Neuroinflammation 2018"},{"issue":"11","key":"1007_CR45","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.1007\/S10072-022-06302-6","volume":"43","author":"H Sun","year":"2022","unstructured":"Sun H, Li X, Guo Q, Liu S. Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures. Neurol Sci 2022. 2022;43(11):6279\u201398. https:\/\/doi.org\/10.1007\/S10072-022-06302-6. 43.","journal-title":"Neurol Sci 2022"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-026-01007-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-026-01007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-026-01007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:27:57Z","timestamp":1790087277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12868-026-01007-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1007"],"URL":"https:\/\/doi.org\/10.1186\/s12868-026-01007-4","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Affiliations 1 and 2 were incomplete in the original publication, this article has been updated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experimentation protocol was approved by the Institutional Animal Ethics Committee, Kasturba Medical College, Manipal Academy of Higher Education (No. IAEC\/KMC\/70\/2016). Study was conducted in accordance with the ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors used ChatGPT to correct for grammars and sentence formation errors. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":4,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28"}}